ORUKA THERAPEUTICS, INC.

NASDAQ: ORKA (Oruka Therapeutics, Inc.)

Last update: yesterday, 10:28PM

11.80

0.59 (5.26%)

Previous Close 11.21
Open 11.18
Volume 217,579
Avg. Volume (3M) 268,177
Market Cap 441,797,920
52 Weeks Range
5.49 (-53%) — 52.32 (343%)
Earnings Date 30 Jul 2025 - 4 Aug 2025
TTM Dividend Yield 13.67%
Total Debt/Equity (MRQ) 0.26%
Current Ratio (MRQ) 30.03
Operating Cash Flow (TTM) -83.80 M

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bearish Bearish
Biotechnology (Global) Bearish Bearish
Stock Oruka Therapeutics, Inc. Bullish -

AIStockmoo Score

0.1
Analyst Consensus 1.5
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 2.5
Technical Oscillators -1.5
Average 0.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ORKA 442 M 13.67% - -
MTSR 3 B - - 5.91
DNTH 595 M - - 1.82
MAZE 550 M - 179.36 1.82
RAPP 415 M - - 1.39
JBIO 353 M - - -

Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.

Sector Healthcare
Industry Biotechnology
% Held by Insiders 3.25%
% Held by Institutions 86.54%
52 Weeks Range
5.49 (-53%) — 52.32 (343%)
Median 40.00 (238.98%)
Total 1 Buy
Firm Date Target Price Call Price @ Call
Wedbush 15 May 2025 40.00 (238.98%) Buy 9.46

No data within this time range.

TTM Dividend Yield 13.67%
1Y Average Dividend Yield 8.32%
Expected Next Dividend Payment Aug 2025
Ex Date Announcement Date Payment Date Details
29 Aug 2024 - 28 Aug 2024 1.613 Cash

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2024 1.61 1 8.32

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria